Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

ConditionsPancreatic Carcinoma Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorOhio State University Comprehensive Cancer Center

About this trial

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Eligibility criteria

Qualifiers

Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN

Immediate surgery cohort: Informed consent will be obtained

Adult patients undergoing pancreatic resection for a presumed IPMN

Disqualifiers

Pregnant

Trial design

Treatments tested in this trial

Optical Coherence Tomography
Therapeutic Conventional Surgery
Laboratory Evaluation

Treatment groups

75 Participants

are divided into 1 treatment group

Sponsors and collaborators

Ohio State University Comprehensive Cancer Center

Lead sponsor

Source ClinicalTrials.gov